Cambridge Scientist Proposes DMT Entities May Be Real Intelligence Operating at Reality's Ground Level
"When you take DMT, your brain starts constructing these entirely alien worlds that are, that are far more complex, far more intricate, far more coherent, and far more real feeling than the normal waking world. It's not like dream, you know. The brain is using those models that it knows to construct a world in the absence of sensory inputs. Which is what dreaming is. So that kind of makes sense. So why then not DMT? Not DMT. Your brain starts constructing these worlds that it shouldn't know how to build."
About this episode
Host AJ interviewed Cambridge-trained neuroscientist Dr. Andrew Gallimore about his 30-year study of DMT, the world's most powerful naturally occurring psychedelic. Gallimore, author of Death by Astonishment, presented his controversial theory that the beings millions report meeting on DMT may be real sentient entities rather than hallucinations. He detailed his development of DMTX with researcher Rick Strassman, an extended-state intravenous protocol that maintains stable breakthrough experiences for hours instead of minutes, now available at a legal Caribbean research facility. The conversation explored why DMT brain activity differs from other psychedelics, collapsing into impossible coherent order rather than random entropy, and why human brains construct alien worlds they never learned to build. Gallimore described the lockout phenomenon where entities explicitly deny access to regular users for years despite identical dosing, and a case where an entity terminated a woman's vision mid-infusion despite DMT still flowing into her brain. He revealed new collaborative work with consciousness theorist Donald Hoffman applying mathematical conscious agent theory to DMT, proposing the molecule gates access to normally imperceptible dimensions of a consciousness-first reality. The discussion covered the evolutionary purpose of endogenous DMT, its neuroprotective role in dying brains, connections to alien abduction experiences, and experimental protocols like the blue-yellow screen test designed to prove DMT entities track external variables subjects cannot know.
Key takeaways
- Gallimore presented brain scan data showing DMT uniquely collapses neural activity into impossible coherent alien order rather than the random entropy produced by other psychedelics.
- Woman's DMT vision terminated mid-session when entity said they were done despite continuous drug infusion maintaining stable brain levels, pharmacologically impossible to explain.
- Lockout phenomenon documented where DMT entities explicitly deny users access for months or years, functioning as on-off switch that cannot be explained by receptor tolerance.
- Gallimore developed DMTX protocol with Rick Strassman enabling stable breakthrough states for hours, now available at legal Eleusis facility in Caribbean for $9,500 plus.
- Collaborative mathematical model with Donald Hoffman's conscious agent theory proposes DMT allows perception of normally imperceptible conscious agents at reality's ground level.
- Rat studies show dying brains flood with neuroprotective DMT binding sigma-1 receptors to preserve oxygen-starved neurons, potentially explaining both evolutionary purpose and near-death visions.
- Five percent of people genetically unable to experience DMT effects at any dose, likely due to receptor polymorphisms, planned for genetic studies at research facility.